Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a...

door Vehreschild, Maria J. G. T., Taori, Surabhi, Goldenberg, Simon D., Thalhammer, Florian, Bouza, Emilio, van Oene, Joop, Wetherill, Graham, Georgopali, Areti
Gepubliceerd in Eur J Clin Microbiol Infect Dis (2018)

Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepati...

door Vehreschild, Maria J. G. T., Taori, Surabhi, Goldenberg, Simon D., Thalhammer, Florian, Bouza, Emilio, van Oene, Joop, Wetherill, Graham, Georgopali, Areti
Gepubliceerd in Eur J Clin Microbiol Infect Dis (2018)